What is teledermatology software?
Teledermatology software is a clinical platform that lets a dermatologist or clinic review skin concerns remotely — typically by reviewing patient-submitted images and a brief questionnaire. It sits alongside an existing clinic workflow and is designed to extend, not replace, in-person care. ScanSkinAI builds teledermatology into its broader AI dermatology software, so async review, AI screening and 3D mole mapping live in one workspace.
What is store-and-forward (asynchronous) teledermatology?
Store-and-forward means the patient submits images and clinical history first; the clinician reviews when convenient and returns a written response. It avoids scheduling friction, supports better image quality than live video, and is generally well-suited to non-urgent skin concerns. For new and solo practices it is often the simplest entry point into virtual care.
Why is teledermatology software priced out of reach for small clinics?
Many teledermatology platforms charge per provider per month (often in the low hundreds of US dollars per provider) or a fee per completed consultation. Both models can scale against a low-volume or seasonal practice, where utilisation is uneven. ScanSkinAI Derm Starter is offered at a flat US$599/yr with no monthly subscription and no per-consult fee — designed to make async teledermatology accessible to solo and small clinics with predictable cost.
How does ScanSkinAI's teledermatology workflow work?
The patient or clinic uploads images and a structured questionnaire. The AI screens the images and surfaces lesions and skin findings. The clinician reviews the AI result alongside the original images, adds professional observations, and decides on monitoring or in-person follow-up. Lesions of interest can be linked to ScanSkinAI's mole mapping software for ongoing tracking, or paired with the chronic skin condition tracker.
How does AI assist remote review?
AI is used as an assistive layer: lesion surfacing, change comparison against earlier images and prioritisation of the review queue. The reviewing dermatologist remains responsible for assessment, suspicion of malignancy and any recommendation for further investigation. Patients exploring the screening side can review our consumer-facing melanoma checker.
Who is it for?
- Solo dermatologists offering remote review
- Independent skin specialists adding a virtual channel
- Small dermatology practices starting teledermatology
- Clinicians adding remote monitoring to existing patients
- Practices piloting virtual care without large upfront cost
Patients searching for a clinician can be referred to our find a dermatologist directory; larger groups can review business solutions.
What are the limitations?
- Cannot diagnose skin cancer, melanoma or any disease.
- Does not replace in-person examination, dermoscopy or biopsy where clinically needed.
- AI is an assistive layer that supports — and does not replace — clinical judgement.
- Image quality (focus, lighting, framing) materially affects what the AI and reviewer can see.
- Not designed for emergencies or urgent care; suspected emergencies should be routed to in-person services.